Article Details
Retrieved on: 2024-05-14 13:56:40
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses a panel's exploration of using both clinical trial and real-world data to assess the effectiveness and safety of CD20-targeting therapies in multiple sclerosis management, emphasizing the value of integrating diverse data sources in clinical practice.
Article found on: www.neurologylive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here